Showing results (691-700 of 2,354) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|February 1, 1994
Lacrimation in Parkinson's diseaseH Bagheri, M Berlan, J M Senard, et al.Clinical Neuropharmacology|October 1, 1992
Elevated plasma immunoreactive beta-endorphin in anorexia nervosaR Tepper, A Weizman, A Apter, et al.Clinical Neuropharmacology|October 22, 2005
Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical studyMarc Ziegenbein, Stefan Kropp, Heike E KuenzelClinical Neuropharmacology|October 22, 2005
Placebo-controlled trial of amantadine in multiple-system atrophyGregor K Wenning, Clinical Neuropharmacology|October 22, 2005
Dopaminergic contribution to the regulation of emotional perceptionPilar Salgado-Pineda, Pauline Delaveau, Olivier Blin, et al.Clinical Neuropharmacology|October 22, 2005
Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson diseaseThomas Müller, Undine E Lang, Siegfried Muhlack, et al.Clinical Neuropharmacology|October 22, 2005
Mirtazapine treatment for pathological laughing and crying after strokeSung-Wan Kim, Il-Seon Shin, Jae-Min Kim, et al.Clinical Neuropharmacology|December 5, 2009
A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystoniaElizabeth Maria Aparecida Barasnevicius Quagliato, Edmur Franco Carelli, Maura Aparecida VianaClinical Neuropharmacology|January 1, 1993
Serotonin selective antidepressant drugs: past, present, futureM Asberg, B MårtenssonClinical Neuropharmacology|August 1, 1993
Bruxism secondary to chronic antidopaminergic drug exposureF Micheli, M Fernandez Pardal, M Gatto, et al.Pageof 236